PMHNP Scope of Practice for Depression in Texas

If you’re a psychiatrist or psychiatric mental health nurse practitioner managing depression patients via telehealth, you’re navigating one of the fastest-evolving regulatory environments in healthcare. Between DEA rule extensions, state-specific prescribing laws, and scope-of-practice variations, it’s easy to feel uncertain about what you can legally do from behind a screen.

Let me cut through the noise: As of early 2026, federal telehealth flexibilities for prescribing controlled substances remain in place through December 31, 2026 — meaning you can continue managing depression patients (including those needing controlled medications for comorbid conditions) via telemedicine without requiring an initial in-person visit. But the details matter, especially when state laws layer on top of federal rules.

This guide walks through what you need to know about prescribing for depression via telehealth — the current DEA rules, how scope of practice differs between psychiatrists and PMHNPs, and what specific state regulations apply in California, Texas, Florida, New York, Pennsylvania, and Illinois.

The Current State of DEA Telehealth Rules (2025–2026)

COVID-Era Flexibilities Extended Through 2026

The DEA and HHS announced a fourth temporary extension of pandemic-era telehealth prescribing rules in January 2026, maintaining the ability to prescribe controlled substances via telemedicine without an in-person exam through December 31, 2026. This extension prevents the ‘telemedicine cliff’ that would have forced providers to revert to strict pre-pandemic requirements under the Ryan Haight Act.

What this means for depression treatment: You can initiate and manage patients via telehealth for depression and related conditions — including prescribing Schedule II stimulants (for comorbid ADHD), benzodiazepines (for anxiety), or other controlled medications — as long as you meet standard-of-care requirements and check your state’s prescription monitoring database.

Understanding the Ryan Haight Act

Under normal circumstances, the Ryan Haight Online Pharmacy Consumer Protection Act requires at least one in-person medical evaluation before prescribing any controlled substance via telemedicine. The law was enacted in 2008 to prevent online ‘pill mills’ and has been a major barrier to telehealth prescribing of medications like Adderall, Xanax, or Ambien.

The COVID Public Health Emergency effectively suspended this requirement, and the DEA has extended these flexibilities multiple times — most recently through end of 2026 — while working on permanent regulations.

For depression prescribers specifically: Most first-line antidepressants (SSRIs, SNRIs, bupropion, mirtazapine) are non-controlled substances and have never been subject to the Ryan Haight Act. You can prescribe these via telehealth anywhere it’s medically appropriate, following state telehealth laws. The DEA rules only come into play when you’re prescribing controlled substances — which becomes relevant for depression patients with comorbid conditions requiring benzodiazepines, stimulants, or certain sleep medications.

What’s Coming Next: Permanent DEA Rules

In January 2025, the DEA proposed new permanent regulations to replace the temporary COVID extensions. Key elements include:

Special Registration for Telemedicine: A proposed registration system that would allow providers to prescribe Schedule III–V controlled substances via telemedicine without an in-person exam. For Schedule II substances (like Adderall, Ritalin, or certain pain medications), the DEA proposes an ‘Advanced Telemedicine Prescribing’ registration available only to qualified specialists — including board-certified psychiatrists.

This means psychiatrists would be explicitly authorized to tele-prescribe Schedule II medications for psychiatric conditions after obtaining this special registration. The DEA is seeking public comment on the specifics, including whether to expand eligibility to other specialties and what safeguards to require.

Platform Registration Requirements: The DEA also proposes requiring telehealth companies and platforms to register with the DEA, aimed at preventing the kind of prescribing abuses that occurred with some pandemic-era startups. If you work through a telehealth platform, that company will need to meet new registration and reporting standards.

What you should do now: Continue prescribing under current flexibilities, but stay informed about the DEA’s final rules (expected late 2026). If you frequently prescribe Schedule II medications for psychiatric conditions, plan to apply for the special telemedicine registration when it becomes available. Document your clinical rationale clearly — especially for controlled substances — as regulatory oversight will likely increase.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Scope of Practice: Psychiatrists vs. PMHNPs

Understanding scope-of-practice differences is critical, especially if you’re considering practicing across state lines via telehealth.

Psychiatrists (MD/DO)

As a physician, you have the broadest scope of practice for depression treatment. You can:

• Diagnose and treat all mental health conditions without supervision
• Prescribe any medication (including all Schedule II–V controlled substances) within your clinical judgment
• Practice independently in all 50 states (with appropriate state licensure)
• Qualify for upcoming DEA special registrations for Schedule II telehealth prescribing

Regulatory requirements: State medical licensure in each state where patients are located, DEA registration for controlled substances in each state of practice, and compliance with state-specific telehealth and prescribing laws.

No supervision needed, ever. The main regulatory consideration is ensuring you’re licensed in the patient’s state and following that state’s telemedicine protocols.

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

PMHNPs are highly trained in psychiatric care and can diagnose and treat depression effectively — but your scope of practice varies dramatically by state. This is where things get complicated.

Full Practice Authority States: In states like California (as of 2024, for experienced NPs), New York (after 3,600 hours), and Illinois (after 4,000 hours plus additional training), you can practice completely independently — no physician oversight, collaboration agreement, or co-signatures required. You can evaluate patients, diagnose conditions, and prescribe medications (including controlled substances in most cases) just like a psychiatrist.

Restricted Practice States: In states like Texas, Florida, and Pennsylvania, you must maintain a collaborative practice agreement with a physician (usually a psychiatrist) to prescribe medications. The physician doesn’t need to be present during telehealth sessions, but they must be available for consultation and involved in your practice oversight.

Schedule II Prescribing Considerations: Even in full-practice states, some states restrict NP prescribing of Schedule II controlled substances (like Adderall or Ritalin). For example, Texas limits Schedule II prescribing by NPs to specific settings. Under the proposed federal rules, the DEA’s ‘Advanced Telemedicine Prescribing’ registration may only be available to physicians (not NPs) for Schedule II substances — though this is still under review.

Bottom line for PMHNPs: Check your state’s nurse practice act carefully. If you have full practice authority, you can operate independently on platforms like Klarity Health in those states. If you need a collaborating physician, you’ll need to arrange that relationship before starting telehealth practice in restricted states.

Practical Comparison

State-by-State Telehealth Prescribing Laws for Depression Care

Each state adds its own layer of regulation on top of federal rules. Here’s what matters in the six priority states:

California

NP Independence: California underwent a major shift with AB 890 (implemented 2023–2024). Qualified PMHNPs with 3+ years of experience can now practice fully independently without physician supervision. This is recent — as of January 2024, ‘104 NPs’ can practice statewide within their specialty (mental health) without any collaboration requirement.

Telehealth Prescribing: No state law requires an in-person exam before prescribing. Telehealth visits must meet the same standard of care as in-person, but a video evaluation is sufficient to establish a patient relationship and prescribe antidepressants or other medications.

Controlled Substances: California defers to federal DEA rules. During the current extension (through 2026), you can prescribe controlled substances via telehealth for psychiatric conditions. California requires checking the state prescription monitoring program (CURES) before prescribing any Schedule II–IV medication.

Licensing: California is not part of the Interstate Medical Licensure Compact (IMLC). You need a full California medical or nursing license to treat patients located in California — no out-of-state telehealth registration available.

What this means for you: California’s large population and progressive telehealth laws make it an attractive market. If you’re a PMHNP with experience, you can practice independently here as of 2024. Psychiatrists face no unusual barriers beyond obtaining a California medical license.

Texas

NP Collaboration: Texas requires all PMHNPs to have a written Prescriptive Authority Agreement with a Texas-licensed physician. No independent NP practice — the physician must be available for consultation and you must meet regularly to discuss cases.

Telemedicine Standards: Texas reformed its telehealth laws in 2017 (SB 1107), allowing practitioners to establish a valid patient relationship via live audio-visual telemedicine. Phone-only is generally insufficient for new patients.

Controlled Substances — The Chronic Pain Exception: Here’s where Texas gets specific: Treatment of chronic pain with controlled substances via telemedicine is prohibited unless the patient has been seen in person or via video in the last 90 days and meets other stringent conditions. This rule is aimed at opioid prescribing for pain management, not psychiatric care.

What this means for depression treatment: You can prescribe antidepressants, benzodiazepines for anxiety, or stimulants for comorbid ADHD via telehealth after a video evaluation. The chronic pain rule doesn’t apply to psychiatric medications. However, if a depression patient also has chronic pain requiring long-term opioids, you’d need an in-person component or refer to a pain specialist.

Licensing: Texas is an IMLC member for physicians (expedited licensing available). Full Texas license required — no special telehealth registration option. PMHNPs need Texas nursing licensure plus a collaborative agreement with a Texas physician.

The bottom line: Texas has huge demand (246 of 254 counties are mental health shortage areas), but you must use video (not phone) for initial evaluations and PMHNPs need a supervising physician on paper.

Florida

NP Scope: Florida’s 2020 law allowing some NP independence explicitly excludes psychiatric NPs. You must have a supervising physician and a signed protocol agreement to practice. Only primary care NPs (family medicine, internal medicine, general pediatrics) can practice autonomously in Florida.

Telehealth Registration: Florida offers an out-of-state telehealth registration option (Florida Statute 456.47), allowing providers licensed in other states to treat Florida patients via telehealth without obtaining a full Florida license. Many psychiatrists use this to expand their practice into Florida’s large patient market.

Controlled Substances — The Psychiatric Exception: Florida law prohibits prescribing Schedule II controlled substances via telehealth — with four specific exceptions: (1) psychiatric disorders, (2) inpatient hospital care, (3) hospice, or (4) nursing home residents.

This is critical for depression prescribers: You can prescribe Schedule II stimulants (Adderall, Ritalin) via telehealth to Florida patients if it’s part of treating a psychiatric condition (like depression with comorbid ADHD). The psychiatric disorder exception explicitly allows this. Schedule III–V medications (like benzodiazepines) have no telehealth restriction.

Licensing: Either obtain a full Florida license or use the out-of-state telehealth registration (renewed every 2 years). Florida is an IMLC member for physicians.

What to know: Florida is relatively friendly to telepsychiatry, especially for physicians. PMHNPs need a Florida-licensed psychiatrist to supervise. Always check Florida’s PDMP (E-FORCSE) before prescribing controlled substances, and document clearly that any Schedule II prescription is for psychiatric treatment.

New York

NP Independence: New York’s 2022 law made permanent the ability for experienced NPs (3,600+ hours) to practice without a written collaborative agreement or physician oversight. This is essentially full practice authority after a couple years of experience. New PMHNPs still need a practice agreement until they hit that threshold.

Telehealth Policy: New York has strong telehealth parity laws and does not require an in-person exam for prescribing. During COVID, New York explicitly allowed audio-only telehealth for mental health services, and many of those flexibilities remain in place.

Controlled Substances: New York follows federal DEA rules with no additional state-level restrictions. Electronic prescribing is mandatory (New York has required e-prescribing since 2016).

Licensing: Must have a New York license (MD or NP). New York is not in the IMLC or APRN compact — you need a full state license. No special telehealth registration.

The takeaway: New York is highly supportive of telehealth mental health services. Psychiatrists have straightforward requirements. PMHNPs with experience can operate completely independently — a significant advantage for building a telehealth practice. Just ensure you’re documenting properly and using e-prescriptions for all medications.

Pennsylvania

NP Collaboration: Pennsylvania has no full practice authority for NPs yet. PMHNPs must have a collaborative agreement with a physician to practice and prescribe. The agreement must be filed with the Pennsylvania Board of Nursing.

Telemedicine Law: Pennsylvania has no comprehensive telehealth statute (several legislative attempts have failed). However, the state Department of State explicitly allows licensed professionals to provide care via telemedicine if it meets the standard of care.

Controlled Substances: Pennsylvania defers to federal DEA rules. The state mandates checking the state PDMP and using e-prescribing for all controlled substances (with limited exceptions).

Licensing: Pennsylvania joined the IMLC for physicians in 2021 (helpful for out-of-state psychiatrists). No special telehealth registration. PMHNPs need a PA nursing license and collaborative agreement.

What you need to know: Pennsylvania’s large rural population makes telepsychiatry essential, and the state reimburses telehealth equivalently to in-person under Medicaid. The lack of formal telehealth laws means you should obtain explicit patient consent for telehealth and document it. PMHNPs will need a collaborating physician, but the physician doesn’t need to attend sessions — just be available for consultation.

Illinois

NP Independence: Illinois offers Full Practice Authority to APRNs (including PMHNPs) who complete 4,000 hours of clinical practice under collaboration plus 250 hours of additional education/training. With FPA, you can diagnose, treat, and prescribe independently — including controlled substances.

Telehealth Law: Illinois’s 2021 Telehealth Expansion Act (Public Act 102-0104) ensured insurance parity for telehealth and explicitly allows telehealth from any location. No in-person exam required if the telehealth encounter meets standard of care.

Controlled Substances: Illinois APRNs with FPA can obtain their own Illinois controlled substance license and DEA registration to prescribe Schedule II–V medications. There’s one nuance: FPA APRNs must have a physician consultation process in place for managing chronic high-dose opioid prescriptions. For typical depression care (including stimulants for ADHD), this doesn’t create barriers.

Licensing: Must have Illinois license (MD or APRN). Illinois is an IMLC member for physicians. The state adopted the APRN Compact in 2023 (not yet active as it requires more member states).

Bottom line: Illinois is highly favorable for telehealth psychiatric practice. If you’re a PMHNP with Full Practice Authority, you can fully manage depression patients without oversight — a big advantage. Psychiatrists face no unusual restrictions. The state actively encourages telepsychiatry to improve access, especially in rural areas outside Chicago.

Quick Reference: State-by-State Comparison

What This Means for Your Practice Economics

Here’s the real talk about building a telepsychiatry practice for depression management:

The DIY Marketing Reality: Acquiring psychiatric patients through traditional marketing channels (SEO, Google Ads, directory listings) typically costs $200–500+ per qualified patient when you factor in all costs:

• SEO takes 6–12 months of consistent investment before generating meaningful traffic, and most solo providers lack the expertise or patience for this
• Google Ads for mental health keywords cost $15–40+ per click, and most clicks don’t convert to booked appointments. A realistic cost per booked patient through PPC is $200–400+
• Directory listings (Psychology Today, Zocdoc) charge monthly fees ($50–300) and you compete with hundreds of other providers on the same page. Zocdoc’s per-booking fees ($35–100+) add up quickly
• Agency/consultant fees, staff time to handle and qualify leads, no-show rates from cold leads, and failed campaign testing further increase your actual patient acquisition cost

For most providers — especially those starting out or scaling — this level of marketing investment and uncertainty is a significant barrier to growing a telehealth practice.

The Platform Model Alternative: Platforms like Klarity Health use a pay-per-appointment model where you pay a standard listing fee per new patient lead. The value proposition:

• No upfront marketing spend or monthly subscription fees — you only pay when a qualified patient books with you
• Pre-qualified patients already matched to your specialty and availability (no wasted time with unqualified leads)
• No ad spend testing or optimization risk — the platform handles patient acquisition
• Built-in telehealth infrastructure included (no separate platform costs to factor in)
• Both insurance and cash-pay patient flow through one platform
• You control your schedule — set your availability and only see patients you choose to accept

The economic advantage: Instead of spending $3,000–5,000/month on marketing with uncertain results, you pay only when you see patients. That’s guaranteed ROI versus gambling on marketing channels that may or may not work.

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience — but for most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk entirely.

Frequently Asked Questions

Can I prescribe antidepressants via telehealth without ever meeting a patient in person?

Yes, in all 50 states (subject to federal and state telehealth laws). Antidepressants like SSRIs, SNRIs, and bupropion are not controlled substances, so the Ryan Haight Act doesn’t apply. As long as you establish a proper patient relationship via a telehealth evaluation (usually video) that meets your state’s standard of care, you can prescribe antidepressants.

What about benzodiazepines or stimulants for depression patients with comorbid anxiety or ADHD?

Under current federal rules (through December 2026), you can prescribe controlled substances including benzodiazepines and stimulants via telehealth without an initial in-person visit. However:

• Some states have additional restrictions (e.g., Texas’s chronic pain rules, Florida’s psychiatric disorder requirement)
• After 2026, you may need a special DEA registration to continue prescribing certain controlled substances via telehealth
• Always check your state’s PDMP and document clinical rationale thoroughly

Do I need a separate DEA registration for each state I practice in?

Yes. If you’re prescribing controlled substances to patients in multiple states via telehealth, you need:

1. A medical or nursing license in each state where patients are located
2. A DEA registration for each state where you prescribe controlled substances

There are no shortcuts here — this is a federal DEA requirement that applies to all telehealth prescribers.

What if my state requires a collaborative agreement but I don’t have a supervising physician?

If you’re a PMHNP in a restricted-practice state (Texas, Florida, Pennsylvania), you cannot practice or prescribe without a collaborative agreement in place. Some options:

• Connect with a psychiatrist willing to serve as your collaborating physician (they may charge a monthly fee)
• Join a platform or group practice that provides collaborating physicians as part of their infrastructure
• Consider obtaining licenses in full-practice states where you can work independently

Can I use phone-only (audio-only) telehealth for depression appointments?

It depends on the state and the clinical situation. Some states (like New York and Illinois) explicitly allow audio-only telehealth for behavioral health services. Others (like Texas) require video for initial evaluations. Always default to video when possible to meet standard of care — audio-only should be reserved for follow-up appointments or situations where video truly isn’t feasible.

What happens to telehealth prescribing after December 31, 2026?

The DEA is expected to finalize permanent rules before the current extension expires. Based on the January 2025 proposals, providers will likely need to:

• Obtain a special telemedicine registration to continue prescribing controlled substances remotely
• Psychiatrists will likely qualify for Schedule II prescribing registration; NPs may be limited to Schedule III–V
• Telehealth platforms will need to register with DEA and meet new reporting requirements

Stay informed by monitoring DEA announcements and professional association guidance (American Psychiatric Association, American Association of Nurse Practitioners).

Do I need malpractice insurance that covers telehealth?

Yes. Most malpractice carriers now include telehealth coverage, but verify with your insurer that:

• Telehealth services are explicitly covered
• All states where you practice are included in your coverage
• Coverage extends to prescribing via telehealth

If you’re joining a platform, ask whether they provide any additional coverage or if you’re responsible for your own policy.

Getting Started With Telehealth Depression Treatment

If you’re ready to expand your practice via telehealth or join a platform like Klarity Health:

1. Verify your licenses and registrations:

• Medical/nursing license in each state where you plan to see patients
• DEA registration in each state (if prescribing controlled substances)
• PDMP registration in each state
• Any required collaborative agreements if you’re an NP in a restricted state

2. Understand your state’s specific rules:

• Review your state medical board or nursing board guidance on telehealth
• Check for any consent requirements or documentation standards
• Understand controlled substance prescribing rules in your state

3. Set up compliant systems:

• HIPAA-compliant video platform
• E-prescribing software that meets DEA requirements (for controlled substances)
• Electronic health record system with telehealth documentation capabilities
• Emergency protocols for managing acute psychiatric crises via telehealth

4. Consider your practice structure:

• Solo independent practice (requires your own marketing, admin, credentialing)
• Join an existing group practice with telehealth infrastructure
• Work through a platform like Klarity Health (handles marketing, patient matching, infrastructure)

5. Stay informed:

• Subscribe to DEA updates on telemedicine regulations
• Follow your state medical or nursing board announcements
• Join professional associations that provide regulatory guidance

The regulatory environment is moving in a favorable direction — expanding access to telepsychiatry while introducing sensible safeguards. For depression-focused providers, telehealth offers tremendous opportunity to reach underserved patients, build a flexible practice, and focus on clinical care rather than administrative overhead.

Ready to explore joining Klarity Health’s network? We handle patient acquisition, credentialing, and infrastructure so you can focus on what you do best — providing excellent psychiatric care to patients who need it. [Learn more about joining our provider network →]

References and Sources

1. U.S. Department of Health and Human Services. (January 2, 2026). HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration. (January 16, 2025). DEA Announces Three New Telemedicine Rules to Continue Open Access to Care. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Florida Legislature. Florida Statute §456.47 – Use of Telehealth to Provide Services. (Accessed February 2026). https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

4. Texas Administrative Code Title 22, Part 9 §174.5. Telemedicine Issuance of Prescriptions. (Last updated January 15, 2025). https://txrules.elaws.us/rule/title22chapter174sec.174.5

5. California Board of Registered Nursing. AB 890 Implementation – Nurse Practitioner Practice Authority. (Updated January 2023). https://www.rn.ca.gov/practice/ab890.shtml

This content is for informational purposes and does not constitute legal or medical advice. Providers should consult their state medical or nursing board, legal counsel, and professional associations for guidance on specific practice situations. Regulations are subject to change.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service